Back to MW MARSHALL WACE, LLP
SAVA
Showing 7 of 17 quarters
Position history for MWMARSHALL WACE, LLP's holdings in FILANA THERAPEUTICS INC
Yes. Marshall Wace holds 1,597,548 shares of SAVA (Filana Therapeutics), worth $1.9M, as of its Q2 2026 13F filing. It reduced the position by 414,995 shares (-20.6%) from Q1 2026. Marshall Wace has held SAVA since Q2 2025, across 5 quarterly 13F filings.
Current Value
$1.9M
Current Shares
1.6M
Total Value Change
+$1.9M
Total Shares Change
+1.6M
Quarter-by-Quarter History